Prescription Care Pharmacy v. Optumrx CA4/3

CourtCalifornia Court of Appeal
DecidedAugust 24, 2020
DocketG057279
StatusUnpublished

This text of Prescription Care Pharmacy v. Optumrx CA4/3 (Prescription Care Pharmacy v. Optumrx CA4/3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Prescription Care Pharmacy v. Optumrx CA4/3, (Cal. Ct. App. 2020).

Opinion

Filed 8/24/20 Prescription Care Pharmacy v. Optumrx CA4/3

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION THREE

PRESCRIPTION CARE PHARMACY, LLC, G057279 Plaintiff and Respondent, (Super. Ct. No. 30-2018-01014006) v. OPINION OPTUMRX, INC.,

Defendant and Appellant.

Appeal from an order of the Superior Court of Orange County, Nathan R. Scott, Judge. Affirmed in part, reversed in part, and remanded with directions. Foley & Lardner, Kimberly A. Klinsport, Irina N. Kashcheyeva, John J. Atallah, and Kristina M. Fernandez Mabrie for Defendant and Appellant. Dorros Law and Torin A. Dorros for Plaintiff and Respondent. * * * This appeal presents for our review an example of what can happen when over-lawyering muddles a simple concept into opaque and sometimes inconsistent language. If the parties wish to arbitrate a dispute, their agreement should say so in plain language. Here, the parties’ contract created an overly complex alternative dispute resolution procedure which resulted in more litigation, not less. Defendant OptumRx, Inc. appeals from an order denying its motion to compel arbitration. Defendant raises two arguments on appeal. First, defendant contends the court erred by itself determining whether the parties’ dispute was arbitrable rather than allowing a panel of arbitrators to determine which claims were arbitrable. Second, assuming the court correctly determined the parties had not delegated the question of arbitrability to a panel of arbitrators, defendant argues the court erred by finding plaintiff’s claims did not fall within the scope of the parties’ arbitration agreement. For the reasons below, we disagree with defendant’s first contention but agree with its second. We accordingly reverse in part and remand for the court to determine in the first instance whether the parties’ arbitration agreement was unconscionable, an issue the court did not reach because of its ruling on the scope of the arbitration agreement.

FACTS

Plaintiff Prescription Care Pharmacy, LLC is an independent pharmacy located in Hollywood, Florida. Defendant is a pharmacy benefit manager that manages pharmacy benefits for various health insurance plans. Plaintiff contracted with defendant to fill prescriptions for members of defendant’s health plans. Two separate contracts governed the terms of their relationship, and plaintiff was further bound by defendant’s provider manuals, which were periodically updated and provided to participating pharmacies. The alternative dispute resolution provisions in these documents are relevant to this appeal.

2 The Relevant Alternative Dispute Resolution Provisions A. The 2015 Provider Manual Defendant’s 2015 manual (the 2015 Provider Manual), which is central to this case, included the following alternative dispute resolution provision: “Other than with respect to issues giving rise to immediate termination hereof or non-renewal hereof, the parties will work in good faith as set forth below to resolve any and all issues and/or disputes between them (hereinafter referred to as a ‘Dispute’) including, but not limited to all questions of arbitrarily [sic], the existence, validity, scope, interpretation or termination of the Agreement or [Provider Manual] or any term thereof prior to the inception of any litigation or arbitration.” The provision also stated: “In the event a Dispute arises, the party asserting the Dispute shall provide written notice to the other party identifying the nature and scope of the Dispute to the other party sufficient for a reasonable person to be apprised thereof. If the parties are unable to resolve the Dispute within thirty (30) days after such notice is provided, then either party may request in writing a meeting or telephone conference to resolve the Dispute . . . . [¶] If the party asserting the Dispute has satisfied the requirements of this section thereof, it shall thereafter be submitted to binding arbitration before a panel of three (3) arbitrators in accordance with the Commercial Dispute Procedures of the American Arbitration Association . . . .” The provision further stated: “In the event that any portion of this section or any part of this Agreement is deemed to be unlawful, invalid or unenforceable, such unlawfulness, invalidity or unenforceability shall not serve to invalidate any other part of this section or this Agreement. In the event any court determines this arbitration proceeding is not binding or otherwise allows litigation involving a dispute to proceed, the parties hereby waive any and all right to trial by jury in or with respect to such litigation, and such litigation would instead proceed with the judge as the finder of fact.” Finally, the provision stated: “For purposes of clarity, only the arbitration provisions in

3 this section shall apply to any Network Pharmacy Provider terminations or other determinations made as to a Network Pharmacy Provider’s status as a participating Network Pharmacy Provider in the Administrator network, pursuant to the [Network Pharmacy Evaluation Committee] review process as stated in the [Provider Manual]. The laws of the State of California and the laws of the United States (U.S.) applicable therein will govern as to the interpretation, validity and effect of the Agreement, the [Provider Manual] and any addendums.”

B. The 2008 Provider Agreement and 2011 Pharmacy Network Agreement In addition to the 2015 Provider Manual, two separate contracts governed the terms under which plaintiff agreed to provide prescription services to members of defendant’s plan clients. The first contract was a 2008 provider agreement between plaintiff and defendant’s predecessor-in-interest (the 2008 Provider Agreement). The 2008 Provider Agreement included the following dispute resolution provision: “The parties will make a good faith effort to resolve any disputes arising during the term of this Agreement. If they are unable to resolve the dispute through informal discussions, either party may submit a written complaint to the other party describing and proposing a manner of resolving that dispute. The party receiving that complaint will respond by accepting, rejecting, or modifying that proposal, in writing, within thirty (30) days of the date that it receives the complaint.” “If the parties are unable to resolve the dispute in accordance with the procedures set forth . . . above, either party may submit the dispute to binding arbitration in accordance with the Rules for the Conduct of Arbitration of the American Arbitration Association (the ‘Rules’) in effect at the date of commencement of such arbitration by one (1) arbitrator who will be appointed by the American Arbitration Association. The arbitration will take place in Illinois, and will be final and binding.” The second contract was a 2011 pharmacy network agreement between plaintiff and a company that later changed its name to OptumRx Inc., the defendant in

4 this case (the 2011 Pharmacy Network Agreement). That agreement included a dispute resolution provision that was almost identical in substance to the above-referenced provisions in the 2015 Provider Manual.

Plaintiff’s Complaint In 2018, plaintiff filed a complaint against defendant alleging defendant wrongfully terminated plaintiff from its pharmacy network. According to the complaint, plaintiff submitted millions of dollars in claims to defendant for compound medication prescriptions, which defendant had to pre-approve before plaintiff could provide the medications.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Avery v. Integrated Healthcare Holdings CA4/3
218 Cal. App. 4th 50 (California Court of Appeal, 2013)
Titolo v. Cano
68 Cal. Rptr. 3d 616 (California Court of Appeal, 2007)
Parada v. Superior Court
176 Cal. App. 4th 1554 (California Court of Appeal, 2009)
Cione v. Foresters Equity Services, Inc.
58 Cal. App. 4th 625 (California Court of Appeal, 1997)
Dream Theater, Inc. v. Dream Theater
21 Cal. Rptr. 3d 322 (California Court of Appeal, 2004)
Balandran v. Labor Ready, Inc.
22 Cal. Rptr. 3d 441 (California Court of Appeal, 2004)
Bruni v. Didion
73 Cal. Rptr. 3d 395 (California Court of Appeal, 2008)
Rodriguez v. American Technologies, Inc.
39 Cal. Rptr. 3d 437 (California Court of Appeal, 2006)
Henry Schein, Inc. v. Archer & White Sales, Inc.
586 U.S. 63 (Supreme Court, 2019)
Hartley v. Superior Court
196 Cal. App. 4th 1249 (California Court of Appeal, 2011)
Peleg v. Neiman Marcus Group, Inc.
204 Cal. App. 4th 1425 (California Court of Appeal, 2012)
Ramos v. Superior Court of San Francisco Cnty.
239 Cal. Rptr. 3d 679 (California Court of Appeals, 5th District, 2018)
Howard v. Goldbloom
241 Cal. Rptr. 3d 743 (California Court of Appeals, 5th District, 2018)
In re Calhoun Motors, Inc.
55 F. Supp. 397 (D. Maryland, 1944)

Cite This Page — Counsel Stack

Bluebook (online)
Prescription Care Pharmacy v. Optumrx CA4/3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/prescription-care-pharmacy-v-optumrx-ca43-calctapp-2020.